Kymo Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Kymo Therapeutics General Information

Description

Operator of a biotechnology company intended to focus on the early development of KMO (kynurenine metabolism) inhibitors. The company offers inhibitors that are meant for the treatment of metabolic and immune or inflammatory diseases, enabling partners to access complete growth and commercialization.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kymo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 16-Jul-2024 Completed Out of Business
1. Early Stage VC (Series A) 19-Sep-2016 Completed Startup
To view Kymo Therapeutics’s complete valuation and funding history, request access »

Kymo Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Kymo Therapeutics’s complete cap table history, request access »

Ready to get started?

Request a free trial

Kymo Therapeutics FAQs

  • When was Kymo Therapeutics founded?

    Kymo Therapeutics was founded in 2016.

  • Where is Kymo Therapeutics headquartered?

    Kymo Therapeutics is headquartered in Cambridge, United Kingdom.

  • What industry is Kymo Therapeutics in?

    Kymo Therapeutics’s primary industry is Biotechnology.

  • Is Kymo Therapeutics a private or public company?

    Kymo Therapeutics is a Private company.

  • What is Kymo Therapeutics’s current revenue?

    The current revenue for Kymo Therapeutics is .

  • How much funding has Kymo Therapeutics raised over time?

    Kymo Therapeutics has raised $11.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process